Table 6.
Semi-maximum prevalence and interpolated age shift of selected concomitant co-morbidities 2010
| Disease | Men | Women | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| (Year 2010) | Age at semi-maximum (prevalence at semi-maximum, R2) | Age shift (years) | Age at semi-maximum (prevalence at semi-maximum, R2) | Age shift (years) | Age atsemi-maximum (prevalence at semi-maximum, R2) | Age shift (years) | |||
| Without T2DM. | With T2DM | Without T2DM | With T2DM | Without T2DM | With T2DM | ||||
| Adiposity | 38.0 (5.07, 0.95) | 24.7 (16.97, 0.99) | 13 | 31.8 (7.88, 0.96) | <20* (24.50, 1.00) | NC | 34.3 (6.59, 0.96) | 21.9 (20.56, 0.99) | 12 |
| Hypertension | 56.5 (34.74, 0.97) | 37.7 (42.39, 0.98) | 19 | 60.8 (37.58, 0.97) | 40.9 (44.21, 0.97) | 20 | 60.5 (36.56, 0.97) | 40.3 (43.54, 0.98) | 20 |
| Coronary heart disease | 69.7 (16.74, 0.99) | 61.5 (21.51, 0.98) | 8 | 72.8 (12.38, 0.97) | 68.9 (16.53, 1.00) | 4 | 70.5 (13.42, 0.99) | 62.5 (17.64, 0.98) | 8 |
| Stroke | 71.1 (3.05, 0.97) | 67.6 (4.45, 0.98) | 5 | 74.2 (2.45, 0.94) | 70.2 (3.45, 0.99) | 4 | 72.2 (2.59, 0.97) | 67.8 (3.66, 0.99) | 4 |
| Renal insufficiency | 73.0 (6.97, 0.96) | 66.1 (8.13, 0.97) | 7 | 74.4 (4.54, 0.93) | 66.0 (5.64, 0.98) | 8 | 72.7 (5.12, 0.96) | 64.0 (6.19, 0.99) | 9 |
| Retinopathy | 70.3 (9.53, 0.98) | 45.7 (15.60, 0.95) | 25 | 69.0 (10.32, 0.96) | 48.9 (16.39, 0.92) | 20 | 69.1 (9.79, 0.97) | 47.9 (16.07, 0.94) | 21 |
The age and prevalence of concomitant co-morbidities at semi-maximum values are shown comparing insured persons with and without type 2 diabetes mellitus (T2DM) after standardization for age and sex on the residual population of South Western Germany. R2 is the goodness of fit from the respective regression model calculating the curves. For this analysis the age groups of 20 years and older were considered only
(* The intersection with the fitted curve and the semi-maximum is located at a time point below 20 years. Therefore, the age shift is not calculable (NC).)